Vishnu Chemicals Q3 FY26: Modest Growth Amid Rising Interest Costs

1 hour ago
share
Share Via
Vishnu Chemicals Limited, a Hyderabad-based specialty chromium chemicals manufacturer, reported a marginal decline in net profit for Q3 FY26, with earnings of ₹33.76 crores compared to ₹34.40 crores in Q3 FY25, representing a year-on-year decline of 1.86%. However, on a sequential basis, the company posted a modest improvement of 2.68% from Q2 FY26's ₹32.88 crores. The stock traded at ₹522.45 on January 30, 2026, up 1.20% from the previous close, giving the company a market capitalisation of ₹3,453 crores.
Vishnu Chemicals Q3 FY26: Modest Growth Amid Rising Interest Costs



The quarter's performance reflects a mixed narrative: whilst revenue growth remained healthy at 10.80% year-on-year to reach ₹411.33 crores, profitability was constrained by rising interest costs and margin compression. Operating margins excluding other income declined to 15.08% from 17.15% in the year-ago quarter, signalling pressure on operational efficiency despite higher sales volumes.





Net Profit (Q3 FY26)

₹33.76 Cr

▼ 1.86% YoY



Revenue Growth

10.80%

YoY Growth



Operating Margin (Excl OI)

15.08%

▼ 207 bps YoY



PAT Margin

8.25%

▼ 104 bps YoY




The Hyderabad-based company, which serves diverse industries including steel, glass, pharmaceuticals, pigments, dyes, and leather through its three manufacturing facilities, has maintained a stable promoter holding of 69.21% whilst institutional participation remains modest at 7.90%. The company's performance must be viewed against the backdrop of a challenging operating environment characterised by elevated raw material costs and increased financing expenses.



Quarterly Performance Trajectory: Growth Momentum Sustained

















































































Metric Dec'25 Sep'25 Jun'25 Mar'25 Dec'24
Net Sales (₹ Cr) 411.33 401.15 346.92 392.63 371.22
QoQ Growth +2.54% +15.63% -11.64% +5.77% +7.96%
YoY Growth +10.80% +16.67% +2.38%
Net Profit (₹ Cr) 33.76 32.88 32.22 38.94 34.40
QoQ Growth +2.68% +2.05% -17.26% +13.20% +50.61%
YoY Growth -1.86% +43.96% +5.74%
Operating Margin (Excl OI) 15.08% 14.56% 16.11% 16.38% 17.15%
PAT Margin 8.25% 8.22% 9.31% 9.96% 9.29%



The quarterly trend reveals a consistent revenue growth trajectory, with Q3 FY26 marking the highest quarterly sales in the company's recent history. However, profitability has not kept pace with top-line expansion, primarily due to margin pressures and rising financing costs. The company's nine-month performance for FY26 shows cumulative net sales of ₹1,159.40 crores against ₹1,053.93 crores in the corresponding period of FY25, reflecting healthy growth momentum of 10.01%.



Financial Performance: Revenue Strength Offset by Cost Pressures



In Q3 FY26, Vishnu Chemicals achieved net sales of ₹411.33 crores, representing a year-on-year growth of 10.80% and a sequential improvement of 2.54%. This marks the company's strongest quarterly revenue performance, surpassing the previous peak of ₹401.15 crores in Q2 FY26. The consistent top-line expansion reflects robust demand from the company's diverse customer base across steel, glass, and pharmaceutical sectors.



However, the revenue growth story is tempered by significant margin compression. Operating profit before depreciation, interest, tax, and other income (PBDIT excluding OI) stood at ₹61.74 crores with a margin of 15.08%, down from 17.15% in Q3 FY25. This 207 basis points contraction in operating margins signals deteriorating operational efficiency, likely driven by elevated raw material costs and competitive pricing pressures in the specialty chemicals segment.





Net Sales (Q3 FY26)

₹411.33 Cr

▲ 10.80% YoY



Net Profit (Q3 FY26)

₹33.76 Cr

▼ 1.86% YoY



Operating Margin (Excl OI)

15.08%

▼ 207 bps YoY



PAT Margin

8.25%

▼ 104 bps YoY




The profit after tax margin declined to 8.25% from 9.29% in the year-ago quarter, reflecting the combined impact of lower operating margins and higher interest expenses. Interest costs surged to ₹13.52 crores in Q3 FY26 from ₹10.26 crores in Q3 FY25, representing a substantial increase of 31.77%. This sharp rise in financing costs has emerged as a critical concern, compressing net profitability despite revenue growth.



On a positive note, other income contributed ₹6.18 crores in the quarter, though this was lower than the ₹9.37 crores reported in Q2 FY26. The tax rate for Q3 FY26 stood at 22.52%, lower than the 28.17% in the previous quarter, providing some relief to bottom-line performance. Employee costs increased to ₹21.82 crores from ₹17.56 crores year-on-year, reflecting inflationary pressures and potential workforce expansion to support business growth.



Operational Challenges: Interest Burden and Margin Erosion



The most significant operational challenge facing Vishnu Chemicals is the deteriorating relationship between operating profit and interest expenses. In Q3 FY26, the operating profit to interest coverage ratio declined to 4.57 times, marking the lowest level in recent quarters. This represents a concerning trend, as the company's ability to service its debt obligations from operational cash flows has weakened considerably.



The company's return on capital employed (ROCE) for the half-year period stood at 15.78%, the lowest recorded level in recent periods. Whilst this remains respectable in absolute terms, the declining trend raises questions about capital efficiency and the returns being generated on the company's expanding asset base. The company's fixed assets increased to ₹701.69 crores in FY25 from ₹634.53 crores in FY24, indicating significant capital expenditure that has yet to translate into proportionate profit growth.




Key Concern: Rising Debt Servicing Costs


Interest expenses have surged 31.77% year-on-year to ₹13.52 crores in Q3 FY26, the highest quarterly interest burden on record. With long-term debt at ₹159.37 crores and the debt-to-EBITDA ratio at 2.14 times, the company faces elevated financial leverage at a time when interest rates remain elevated. The operating profit to interest coverage has declined to 4.57 times, signalling reduced financial flexibility.




From a balance sheet perspective, the company maintains a debt-to-equity ratio of 0.42 times (as of H1 FY26), which is relatively moderate. However, the net debt to equity ratio of 0.27 times indicates that after accounting for cash reserves, the company's leverage position is manageable. Cash and cash equivalents stood at ₹149.80 crores for the half-year period, the highest recorded level, providing a cushion for working capital requirements and debt servicing.



The company's working capital management has come under pressure, with changes in working capital absorbing ₹107.00 crores in FY25 compared to ₹108.00 crores in FY24. This persistent working capital intensity reflects the capital-intensive nature of the specialty chemicals business and the need for substantial inventory and receivables to support sales growth. Current assets increased to ₹837.74 crores in FY25 from ₹655.16 crores in FY24, whilst current liabilities rose to ₹492.03 crores from ₹415.89 crores, indicating expansion in the operating cycle.



Industry Context: Navigating Specialty Chemicals Headwinds



The specialty chemicals sector in India has faced a challenging operating environment over the past year, with margin pressures stemming from volatile raw material costs, overcapacity in certain segments, and subdued demand from key end-user industries. Vishnu Chemicals' performance must be evaluated within this broader industry context, where companies have struggled to pass on cost increases to customers amid competitive intensity.



The company's diverse customer base across steel, glass, pharmaceutical, pigments, dyes, and leather industries provides some insulation from sector-specific downturns. However, the cyclical nature of several of these end-markets means that demand volatility remains an inherent risk. The steel industry, a significant consumer of chromium chemicals, has experienced mixed performance with pricing pressures affecting margins across the value chain.




Competitive Positioning in Chromium Chemicals


Vishnu Chemicals operates in the niche chromium chemicals segment with three manufacturing facilities in India. The company's established presence and wide customer base across multiple industries provide competitive advantages in terms of diversification and customer relationships. However, the company faces competition from both domestic players and imports, particularly from China, which can impact pricing power and margins during periods of demand softness.




The company's long-term growth trajectory remains intact, with five-year sales growth of 18.22% and EBIT growth of 30.16% demonstrating the underlying strength of the business model. However, the recent quarterly performance suggests that near-term challenges related to margin protection and cost management require focused attention from management.



Peer Comparison: Valuation and Operational Metrics

































































Company P/E (TTM) P/BV ROE (%) Debt/Equity Div Yield (%)
Vishnu Chemicals 25.40 3.52 20.05 0.27 0.06
Archean Chemical 40.44 3.63 16.06 0.05 0.54
Galaxy Surfactants 22.40 2.53 16.22 -0.15 1.22
Epigral 11.18 2.14 24.93 0.24 0.24
Laxmi Organic 49.42 2.04 8.76 0.10 0.35
Balaji Amines 25.14 1.92 18.28 -0.08 0.98



Vishnu Chemicals trades at a price-to-earnings multiple of 25.40 times, which is below the industry average of approximately 39 times but in line with peers like Balaji Amines (25.14x) and Galaxy Surfactants (22.40x). The company commands a premium price-to-book value ratio of 3.52 times, higher than most peers except Archean Chemical (3.63x), reflecting market recognition of the company's asset quality and growth potential.



The company's return on equity of 20.05% stands out favourably compared to the peer group average of approximately 17%, demonstrating superior capital efficiency. This higher ROE justifies the premium valuation to some extent, as the company generates stronger returns on shareholder equity than most competitors. However, the company's minimal dividend yield of 0.06% lags significantly behind peers, with the company retaining most earnings for growth investments rather than distributing cash to shareholders.



From a leverage perspective, Vishnu Chemicals maintains a moderate debt-to-equity ratio of 0.27, which is higher than Archean Chemical (0.05) and Laxmi Organic (0.10) but lower than Epigral (0.24). This balanced capital structure provides financial flexibility whilst maintaining reasonable leverage to support growth initiatives. The company's market capitalisation of ₹3,453 crores positions it as a mid-sized player in the specialty chemicals space, smaller than established names but with demonstrated growth momentum.



Valuation Analysis: Fair Pricing with Limited Margin of Safety



At the current market price of ₹522.45, Vishnu Chemicals trades at a trailing twelve-month P/E ratio of 25.40 times, representing a discount to the industry average of 39 times but a premium to the broader market. The company's PEG ratio of 0.78 suggests that the stock is reasonably valued relative to its growth prospects, with the sub-1.0 reading indicating that investors are not paying an excessive premium for future earnings growth.



The price-to-book value of 3.52 times represents a significant premium to the company's net asset value of ₹137.67 per share, reflecting market expectations of future profitability and return generation. This valuation multiple is justified by the company's superior ROE of 20.05%, which demonstrates efficient capital utilisation. However, the recent deterioration in financial metrics suggests that sustaining this premium valuation will require a return to margin expansion and improved operational performance.





P/E Ratio (TTM)

25.40x

vs Industry 39x



Price to Book

3.52x

Book Value: ₹137.67



Dividend Yield

0.06%

₹0.30 per share



Mojo Score

61/100

HOLD Rating




The enterprise value to EBITDA multiple of 15.68 times and EV/EBIT of 18.81 times suggest moderate valuation levels, though these multiples have compressed from historical peaks as profitability growth has moderated. The stock's 52-week range of ₹340.00 to ₹596.00 indicates significant volatility, with the current price positioned 12.34% below the yearly high and 53.66% above the low. This positioning suggests that whilst the stock has recovered substantially from its lows, it has not yet reclaimed previous peak valuations.



The company's valuation grade has transitioned from "Very Expensive" to "Fair" over recent months, reflecting both the stock's price correction and moderation in earnings momentum. The current "Fair" valuation assessment suggests limited margin of safety for investors, with the stock neither offering compelling value nor appearing significantly overpriced at prevailing levels.



Shareholding Pattern: Stable Promoter Base, Modest Institutional Interest

































































Shareholder Category Dec'25 Sep'25 Jun'25 Mar'25 QoQ Change
Promoter Holding 69.21% 69.21% 69.21% 69.21% 0.00%
FII Holding 2.20% 2.24% 2.74% 0.82% -0.04%
Mutual Fund Holding 4.79% 4.70% 4.53% 4.82% +0.09%
Insurance Holdings 0.00% 0.00% 0.00% 1.01% 0.00%
Other DII Holdings 0.92% 0.89% 0.89% 0.89% +0.03%
Non-Institutional 22.89% 22.97% 22.63% 23.26% -0.08%



The shareholding pattern reveals a rock-solid promoter base, with Krishna Murthy Cherukuri Cherukuri holding 48.66%, Manjula Cherukuri holding 12.17%, and Cherukuri Siddartha holding 8.37%, collectively maintaining an unchanged 69.21% stake. The absence of any promoter pledging is a significant positive, indicating strong promoter confidence and financial stability at the ownership level.



Institutional participation remains relatively modest, with total institutional holdings at 7.90%. Foreign institutional investors hold 2.20%, showing a marginal decline of 0.04 percentage points in Q3 FY26. This reduction, whilst small, comes after a more significant increase from 0.82% in March 2025 to 2.74% in June 2025, suggesting some profit-booking by FIIs following the stock's strong rally earlier in the year.



Mutual fund holdings increased marginally to 4.79% from 4.70% in the previous quarter, indicating continued interest from domestic institutional investors. Four mutual fund schemes hold positions in the company, providing diversified institutional support. The complete exit of insurance companies from the stock (from 1.01% in March 2025 to 0.00% currently) represents a notable development, potentially reflecting portfolio rebalancing or concerns about near-term performance.



The substantial non-institutional holding of 22.89% indicates strong retail and non-institutional investor interest in the stock. This broad-based retail participation can provide liquidity but may also contribute to higher volatility during periods of market stress or company-specific concerns.



Stock Performance: Long-Term Wealth Creator Despite Recent Volatility





































































Period Stock Return Sensex Return Alpha
1 Week +2.98% +0.90% +2.08%
1 Month -3.60% -2.84% -0.76%
3 Months +7.78% -2.53% +10.31%
6 Months -7.06% +0.97% -8.03%
Year to Date -3.25% -3.46% +0.21%
1 Year +24.14% +7.18% +16.96%
2 Years +66.28% +15.65% +50.63%
3 Years +94.76% +38.27% +56.49%
5 Years +1348.84% +77.74% +1271.10%



Vishnu Chemicals has delivered exceptional long-term wealth creation, with a staggering five-year return of 1,348.84% compared to the Sensex return of 77.74%, generating alpha of 1,271.10 percentage points. This extraordinary performance reflects the company's transformation from a smaller specialty chemicals player to a significant industry participant with expanded manufacturing capacity and market presence.



However, recent performance has been more subdued, with the stock delivering negative returns over the past six months (-7.06%) and one month (-3.60%), underperforming the broader market during these periods. The six-month underperformance of 8.03 percentage points versus the Sensex suggests that investors have grown cautious about near-term prospects amid margin pressures and rising interest costs.



The stock's one-year return of 24.14% significantly outperforms both the Sensex (7.18%) and the specialty chemicals sector (5.34%), generating alpha of 16.96 percentage points. This outperformance demonstrates that despite recent challenges, the market continues to recognise the company's underlying business strength and growth potential.




"Whilst near-term headwinds from margin compression and elevated interest costs warrant caution, the company's five-year wealth creation track record of 1,349% returns speaks to the underlying business quality and long-term growth trajectory."


The stock's high beta of 1.23 indicates greater volatility than the broader market, with risk-adjusted returns of 0.62 compared to the Sensex's 0.64 over the past year. The volatility of 39.10% positions Vishnu Chemicals as a high-risk, high-return investment, suitable primarily for investors with higher risk tolerance and longer investment horizons.



Technical indicators present a mixed picture, with the overall trend classified as "Bullish" as of January 29, 2026. However, the stock trades below all key moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), suggesting that the recent bullish trend reversal requires confirmation through sustained price strength. The 52-week high of ₹596.00 represents a significant resistance level 12.34% above current levels.



Investment Thesis: Quality Business Facing Temporary Headwinds



The investment case for Vishnu Chemicals rests on several fundamental strengths: a robust five-year sales CAGR of 18.22%, impressive EBIT growth of 30.16%, strong return on equity of 20.05%, and zero promoter pledging. The company's established presence in the niche chromium chemicals segment with three manufacturing facilities provides competitive advantages and barriers to entry.



However, the current investment thesis is complicated by near-term challenges. The company's financial trend has turned negative as of December 2025, driven by the lowest ROCE of 15.78% for the half-year period, the weakest operating profit to interest coverage of 4.57 times, and the highest quarterly interest expense of ₹13.52 crores. These factors have contributed to the company's Mojo Score declining to 61 out of 100, resulting in a "HOLD" rating.





Valuation

FAIR

Reasonably Priced



Quality Grade

GOOD

Strong Fundamentals



Financial Trend

NEGATIVE

Near-term Pressure



Technical Trend

BULLISH

Recent Reversal




The company's quality assessment remains "Good," reflecting solid long-term financial performance, but this is offset by the negative short-term financial trend. The valuation at current levels appears "Fair" rather than attractive, providing limited margin of safety for new investors. The recent technical trend reversal to "Bullish" offers some support, though confirmation through sustained price action is needed.



Key Strengths and Risk Factors





✓ KEY STRENGTHS



Exceptional Long-term Returns: Five-year return of 1,348.84% demonstrates outstanding wealth creation capability and business transformation.


Superior Capital Efficiency: ROE of 20.05% significantly exceeds peer average, indicating efficient utilisation of shareholder capital.


Strong Revenue Growth: Five-year sales CAGR of 18.22% and consistent quarterly growth demonstrate robust demand for chromium chemicals.


Zero Promoter Pledging: Stable 69.21% promoter holding with no pledging reflects strong promoter confidence and financial stability.


Diversified Customer Base: Presence across steel, glass, pharmaceutical, pigments, dyes, and leather industries reduces concentration risk.


Healthy Cash Position: Cash and equivalents of ₹149.80 crores (H1 FY26) provides financial flexibility for operations and debt servicing.


Moderate Leverage: Debt-to-equity of 0.42 and net debt-to-equity of 0.27 indicate balanced capital structure with manageable leverage.



⚠ KEY CONCERNS



Margin Compression: Operating margin declined 207 bps YoY to 15.08%, indicating deteriorating operational efficiency and pricing power.


Surging Interest Costs: Interest expenses increased 31.77% YoY to ₹13.52 crores, significantly impacting profitability despite revenue growth.


Weakening Debt Coverage: Operating profit to interest coverage declined to 4.57 times, the lowest in recent quarters, raising debt servicing concerns.


Declining ROCE: Return on capital employed fell to 15.78% in H1 FY26, suggesting reduced efficiency in capital deployment.


Negative Financial Trend: Short-term financial trend turned negative in December 2025, reflecting multiple deteriorating metrics.


Low Institutional Holding: Total institutional ownership of only 7.90% limits institutional support and may impact liquidity during stress.


High Volatility: Beta of 1.23 and volatility of 39.10% indicate significant price swings, unsuitable for risk-averse investors.




Outlook and Key Monitoring Points





POSITIVE CATALYSTS



Margin Recovery: Any improvement in operating margins back towards 16-17% levels would significantly enhance profitability and investor sentiment.


Interest Cost Stabilisation: Plateauing or decline in interest expenses as debt gets repaid or refinanced at better rates.


Capacity Utilisation: Better absorption of fixed costs as recent capital expenditure leads to higher production volumes.


Demand Recovery: Improvement in end-user industries, particularly steel and glass, driving higher volumes and pricing power.


Working Capital Efficiency: Reduction in working capital intensity freeing up cash for debt reduction and growth investments.



RED FLAGS TO WATCH



Further Margin Erosion: Operating margins falling below 15% would signal serious competitive or cost management challenges.


Rising Debt Levels: Increase in debt-to-EBITDA ratio beyond 2.5 times would raise concerns about financial flexibility.


Deteriorating Coverage: Operating profit to interest coverage falling below 4.0 times would indicate stressed debt servicing capability.


Promoter Stake Reduction: Any decline in the stable 69.21% promoter holding would be a significant negative signal.


Institutional Exodus: Further reduction in already-low institutional holdings would limit market support and liquidity.




The near-term outlook for Vishnu Chemicals hinges critically on management's ability to arrest margin compression and stabilise interest costs. Investors should closely monitor quarterly margin trends, debt reduction progress, and capacity utilisation levels. The company's long-term growth story remains intact, supported by industry tailwinds and established market position, but execution on operational efficiency will determine whether the stock can resume its wealth-creation trajectory.




The Verdict: Quality Business at Fair Value, But Wait for Clarity


HOLD

Score: 61/100


For Fresh Investors: Not recommended for fresh buying at current levels. Whilst the long-term track record is impressive, near-term challenges around margin compression, rising interest costs, and negative financial trend warrant caution. The "Fair" valuation provides limited margin of safety. Wait for signs of operational improvement, particularly margin stabilisation and interest cost control, before initiating positions. Better entry opportunities may emerge if the stock corrects towards ₹480-500 levels or if quarterly results show meaningful improvement in key metrics.


For Existing Holders: Continue to hold with close monitoring of quarterly performance. The company's strong long-term fundamentals, superior ROE of 20.05%, zero promoter pledging, and established market position justify maintaining exposure. However, set strict review triggers: consider reducing positions if operating margins fall below 14% or if operating profit to interest coverage deteriorates below 4.0 times. The five-year wealth creation track record of 1,349% returns warrants patience, but not complacency.


Fair Value Estimate: ₹550-580 per share (5-11% upside from current levels). This valuation assumes gradual margin recovery to 16% levels over the next 12-18 months and stabilisation of interest costs. The estimate is based on 22-24x forward earnings, in line with peer valuations adjusted for the company's superior ROE but tempered by near-term execution challenges.





Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)





⚠️ Investment Disclaimer


This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. The stock market involves risk, and investors may lose some or all of their invested capital.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News